252 related articles for article (PubMed ID: 30122369)
1. Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
Balestri F; Quattrini L; Coviello V; Sartini S; Da Settimo F; Cappiello M; Moschini R; Del Corso A; Mura U; La Motta C
Cell Chem Biol; 2018 Nov; 25(11):1414-1418.e3. PubMed ID: 30122369
[TBL] [Abstract][Full Text] [Related]
2. In Search of Differential Inhibitors of Aldose Reductase.
Balestri F; Moschini R; Mura U; Cappiello M; Del Corso A
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454074
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase inhibitors: 2013-present.
Quattrini L; La Motta C
Expert Opin Ther Pat; 2019 Mar; 29(3):199-213. PubMed ID: 30760060
[TBL] [Abstract][Full Text] [Related]
4. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.
Kumar M; Choudhary S; Singh PK; Silakari O
Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375
[TBL] [Abstract][Full Text] [Related]
5. The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.
Gupta JK
Curr Pharm Biotechnol; 2024; 25(9):1073-1081. PubMed ID: 37649296
[TBL] [Abstract][Full Text] [Related]
6. Aldose Reductase Differential Inhibitors in Green Tea.
Balestri F; Poli G; Pineschi C; Moschini R; Cappiello M; Mura U; Tuccinardi T; Del Corso A
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32640594
[TBL] [Abstract][Full Text] [Related]
7. Edible vegetables as a source of aldose reductase differential inhibitors.
Balestri F; Sorce C; Moschini R; Cappiello M; Misuri L; Del Corso A; Mura U
Chem Biol Interact; 2017 Oct; 276():155-159. PubMed ID: 28159579
[TBL] [Abstract][Full Text] [Related]
8. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
9. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
Molecules; 2021 May; 26(10):. PubMed ID: 34066081
[TBL] [Abstract][Full Text] [Related]
10. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.
Thakur S; Gupta SK; Ali V; Singh P; Verma M
Arch Pharm Res; 2021 Jul; 44(7):655-667. PubMed ID: 34279787
[TBL] [Abstract][Full Text] [Related]
11. From a dull enzyme to something else: facts and perspectives regarding aldose reductase.
Del Corso A; Cappiello M; Mura U
Curr Med Chem; 2008; 15(15):1452-61. PubMed ID: 18537622
[TBL] [Abstract][Full Text] [Related]
12. Identification of quinoxalin-2(1
Hao X; Qin X; Zhang X; Ma B; Qi G; Yu T; Han Z; Zhu C
Future Med Chem; 2019 Dec; 11(23):2989-3004. PubMed ID: 31659919
[No Abstract] [Full Text] [Related]
13. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications.
Vander Jagt DL; Hassebrook RK; Hunsaker LA; Brown WM; Royer RE
Chem Biol Interact; 2001 Jan; 130-132(1-3):549-62. PubMed ID: 11306074
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
[TBL] [Abstract][Full Text] [Related]
15. Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
Papastavrou N; Chatzopoulou M; Ballekova J; Cappiello M; Moschini R; Balestri F; Patsilinakos A; Ragno R; Stefek M; Nicolaou I
Eur J Med Chem; 2017 Apr; 130():328-335. PubMed ID: 28259841
[TBL] [Abstract][Full Text] [Related]
16. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
18. 1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitors.
Papastavrou N; Chatzopoulou M; Pegklidou K; Nicolaou I
Bioorg Med Chem; 2013 Sep; 21(17):4951-7. PubMed ID: 23891165
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan S
Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
[TBL] [Abstract][Full Text] [Related]
20. A new approach to control the enigmatic activity of aldose reductase.
Del-Corso A; Balestri F; Di Bugno E; Moschini R; Cappiello M; Sartini S; La-Motta C; Da-Settimo F; Mura U
PLoS One; 2013; 8(9):e74076. PubMed ID: 24019949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
